scholarly journals Paediatric cyclical Cushing’s disease due to corticotroph cell hyperplasia

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
E. Noctor ◽  
S. Gupta ◽  
T. Brown ◽  
M. Farrell ◽  
M. Javadpour ◽  
...  
2020 ◽  
Vol 0 (1) ◽  
pp. 47-56
Author(s):  
A. V. Solntsava ◽  
N. V. Volkava ◽  
K. A. Beliayeva ◽  
V. A. Zhurauliou

1985 ◽  
Vol 60 (2) ◽  
pp. 328-332 ◽  
Author(s):  
A.B. ATKINSON ◽  
A. CHESTNUTT ◽  
E. CROTHERS ◽  
R. WOODS ◽  
J.A. WEAVER ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Sunita M. C. De Sousa ◽  
Jim Manavis ◽  
Jinghua Feng ◽  
Paul Wang ◽  
Andreas W. Schreiber ◽  
...  

2014 ◽  
Vol 61 (2) ◽  
pp. 69-76
Author(s):  
Alfonso Leal-Cerro ◽  
Juan Francisco Martín-Rodríguez ◽  
Alejandro Ibáñez-Costa ◽  
Ainara Madrazo-Atutxa ◽  
Eva Venegas-Moreno ◽  
...  

1980 ◽  
Vol 94 (3) ◽  
pp. 297-303 ◽  
Author(s):  
Adrian M. Schnall ◽  
Kalman Kovacs ◽  
Jerald S. Brodkey ◽  
Olof H. Pearson

Abstract. Recent reports of patients with Cushing's disease who have been explored via the transsphenoidal route indicate that the great majority has pituitary adenomas. We report a patient with biochemically documented pituitary-based hypercortisolism who had a clinical and biochemical remission following hypophysectomy. Serial sections of the pituitary tissue removed showed hyperplasia of corticotroph cells but no adenoma. Hypophysectomy was complete as documented by serum levels of FSH, LH, TSH, prolactin, hGH and ACTH at the lower limits of the respective assays, with no response to appropriate stimuli. This case demonstrates that a minority of patients with Cushing's disease has corticotroph cell hyperplasia without a pituitary adenoma.


Author(s):  
Rosemary Dineen ◽  
Karen McGurren ◽  
Mohsen Javadpour ◽  
Colm Costigan ◽  
Amar Agha

Neurosurgery ◽  
1987 ◽  
Vol 21 (2) ◽  
pp. 218-222 ◽  
Author(s):  
Toshichi Nakane ◽  
Akio Kuwayama ◽  
Masao Watanabe ◽  
Tatsuo Takahashi ◽  
Tetsuo Kato ◽  
...  

Abstract As part of an ongoing series, 100 patients with Cushing's disease underwent transsphenoidal operations. Pituitary adenomas were confirmed in 93 patients, and initial remission was achieved in 86 (92%) of them. Hypercortisolemia was not corrected in 7 patients, and in 4 this was due to invasive adenomas. These patients were subjected to irradiation, medical treatment, or both after operation. Only 7 of the 100 patients had no pituitary adenoma found at operation, and they obtained no clinical remission even after partial or subtotal hypophysectomy. Follow-up review, with an emphasis on endocrinological studies, was performed on these patients for a mean period of 38 months. Seventy-eight patients were in long term remission after operation and had restoration of noncorticotropic hormone secretion as well as pituitary-adrenal function. Recurrence was noted in 8 patients after 19 to 82 months in remission. In all of these patients, pituitary adenomas were verified by reoperation and no case of corticotrophic cell hyperplasia was noted. We conclude that late recurrence of Cushing's disease may occur after adenoma removal and is due to the regrowth of adenoma cells left behind in the peritumoral tissue at the first operation. In view of the overall remission rate, transsphenoidal adenomectomy is considered a highly effective treatment for Cushing's disease.


2018 ◽  
Vol 129 (5) ◽  
pp. 1260-1267 ◽  
Author(s):  
Steven B. Carr ◽  
Bette K. Kleinschmidt-DeMasters ◽  
Janice M. Kerr ◽  
Katja Kiseljak-Vassiliades ◽  
Margaret E. Wierman ◽  
...  

OBJECTIVEThe authors report their single-institution experience with the pathological findings, rates of remission, and complications in patients with presumed Cushing’s disease (CD) who underwent a two-thirds pituitary gland resection when no adenoma was identified at the time of transsphenoidal surgery (TSS). The authors also review the literature on patients with CD, negative surgical exploration, and histological findings.METHODSThis study is a retrospective analysis of cases found in neurosurgery and pathology department databases between 1989 and 2011. In all cases, patients had been operated on by the same neurosurgeon (K.O.L.). Twenty-two (13.6%) of 161 patients who underwent TSS for CD had no adenoma identified intraoperatively after systematic exploration of the entire gland; these patients all underwent a two-thirds pituitary gland resection. A chart review was performed to assess treatment data points as well as clinical and biochemical remission status.RESULTSOf the 22 patients who underwent two-thirds gland resection, 6 (27.3%) ultimately had lesions found on final pathology. All 6 patients were found to have a distinct adrenocorticotropic hormone (ACTH) cell adenoma. Sixteen (72.7%) of the patients had no tumor identified, with 3 of these patients suspected of having ACTH cell hyperplasia. The follow-up duration for the entire group was between 14 and 315 months (mean 98.9 months, median 77 months). Remission rates were 100% (6/6 patients) for the ACTH cell adenoma group and 75% (12/16) for the group without adenoma. Overall, 18 (81.8%) of the 22 patients had no evidence of hypercortisolism at last follow-up, and 4 patients (18%) had persistent hypercortisolism, defined as a postoperative cortisol level > 5 μg/dl. Of these 4 patients, 1 was suspected of harboring a cavernous sinus adenoma, 2 were found to have lung tumors secreting ACTH, and 1 remained with an undiagnosed etiology. Rates of postoperative complications were low.CONCLUSIONSThe diagnosis and treatment of CD can be challenging for neurosurgeons, endocrinologists, and pathologists alike. Failure to find a discrete adenoma at the time of surgery occurs in at least 10%–15% of cases, even in experienced centers. The current literature provides little guidance regarding rational intraoperative approaches in such cases. The authors’ experience with 161 patients with CD, when no intraoperative tumor was localized, demonstrates the utility of a two-thirds pituitary gland resection with a novel and effective surgical strategy, as suggested by a high initial remission rate and a low operative morbidity.


1995 ◽  
Vol 133 (3) ◽  
pp. 317-319 ◽  
Author(s):  
Hajime Watanobe ◽  
Takeshi Nigawara ◽  
Ryo Nasushita ◽  
Shinsuke Sasaki ◽  
Kazuo Takebe

Watanobe H, Nigawara T, Nasushita R, Sasaki S, Takebe K. A case of cyclical Cushing's disease associated with corticosteroid-binding globulin deficiency: a rare pitfall in the diagnosis of Cushing's disease. Eur J Endocrinol 1995;133:317–9. ISSN 0804–4643 We experienced an extremely unusual combination of Cushing's disease and corticosteroid-binding globulin (CBG) deficiency that has been reported in only one similar case to date. A 53-year-old woman presented at a medical clinic with clinical Cushing's disease. However, her plasma levels of adrenocorticotropin (ACTH) and cortisol were in the normal range. Six months later, during a second visit, a high urinary excretion of 17-hydroxycorticosteroids was found, but plasma ACTH and cortisol levels were normal again. Further investigation revealed a decreased CBG concentration. Free plasma cortisol levels were clearly elevated. Furthermore, the Cushing's disease of our patient was complicated by periodic secretion of ACTH and cortisol, with high or normal outputs of corticosteroids occurring alternately every 1–3 days, which explained the occasionally normal plasma ACTH and cortisol levels. A combination of a decreased serum CBG concentration and periodic secretion of ACTH can be an important pitfall in the diagnosis of Cushing's disease. Hajime Watanobe, Third Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori 036, Japan


2005 ◽  
Vol 35 (3) ◽  
pp. 201-202
Author(s):  
M. D. Reed ◽  
P. G. Colman ◽  
D. Barraclough

Sign in / Sign up

Export Citation Format

Share Document